October 24, 2024 – Placentia, California – Applied Biomedical (ABM), led by Dr. Subhash Varshney, is pleased to announce the acceptance of its abstract, “Advancing Rapid Point-of-Care Diagnostics and Bacteriophage Therapeutics for Drug-Resistant Bacterial Infections,” for presentation as a poster at Respi-DART 2024. This event, co-hosted by the NIH, will be held in Cabo San Lucas, Mexico, from December 4-6, 2024.
Respi-DART is a premier conference dedicated to advancements in respiratory and infectious diseases, gathering global leaders to highlight emerging innovations in diagnostics, therapeutics, and patient care. ABM, under the guidance of Dr. Varshney, will present its cutting-edge rapid point-of-care diagnostics designed to identify drug-resistant bacterial pathogens more efficiently.
“The developments at ABM are positioned to have a global impact on the growing AMR crisis, affecting public health programs globally. The development of a cost-effective rapid thermostable diagnostic capable of identifying drug resistance is an essential public measure with national security implications,” said Dr. Roscoe Moore, former U.S. Assistant Surgeon General.
“We are excited to share our progress at Respi-DART, demonstrating how ABM’s diagnostic tools can transform detection and response to drug-resistant infections,” added William Colton, ABM’s Lead Scientist. “The ability to quickly identify pathogens and tailor treatments aligns with ABM’s mission to improve patient outcomes through advanced, accessible diagnostics.”
The poster will showcase ABM’s diagnostic technology in collaboration with Paldara Pharmaceuticals’ bacteriophage products, presenting a complementary approach that enhances both detection and treatment of drug-resistant infections. ABM’s rapid diagnostics offer a significant step forward in enabling clinicians to make informed treatment decisions more swiftly, potentially reducing the burden of antimicrobial resistance.
For more information about ABM’s research or to schedule a meeting at Respi-DART 2024, please contact:
William Colton, Lead Scientist, Applied Biomedical Inc.
Applied Biomedical led by Dr. Subhash Varshney, focuses on the development of rapid diagnostic solutions to enhance infectious disease detection and treatment. With a commitment to addressing urgent public health challenges, ABM pioneers technologies supporting precise, timely, and effective patient care.
For press inquiries, please contact:
Dr. Prashanth Setty
Investor-info@appliedbiomedical.com
+1 505 573 5156